HL7 Terminology (THO)
6.1.0 - Continuous Process Integration (ci build)
HL7 Terminology (THO)
6.1.0 - Continuous Process Integration (ci build)
HL7 Terminology (THO), published by HL7 International - Vocabulary Work Group. This guide is not an authorized publication; it is the continuous build for version 6.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/UTG/ and changes regularly. See the Directory of published versions
| Active as of 2019-03-20 |
{
"resourceType" : "CodeSystem",
"id" : "v3-substanceAdminSubstitution",
"language" : "en",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><p class=\"res-header-id\"><b>Generated Narrative: CodeSystem v3-substanceAdminSubstitution</b></p><a name=\"v3-substanceAdminSubstitution\"> </a><a name=\"hcv3-substanceAdminSubstitution\"> </a><a name=\"v3-substanceAdminSubstitution-en-US\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Language: en</p></div><p><b>Properties</b></p><p><b>This code system defines the following properties for its concepts</b></p><table class=\"grid\"><tr><td><b>Name</b></td><td><b>Code</b></td><td><b>URI</b></td><td><b>Type</b></td><td><b>Description</b></td></tr><tr><td>Specializes</td><td>Specializes</td><td/><td>Coding</td><td>The child code is a more narrow version of the concept represented by the parent code. I.e. Every child concept is also a valid parent concept. Used to allow determination of subsumption. Must be transitive, irreflexive, antisymmetric.</td></tr><tr><td>Generalizes</td><td>Generalizes</td><td/><td>Coding</td><td>Inverse of Specializes. Only included as a derived relationship.</td></tr><tr><td>internalId</td><td>internalId</td><td>http://terminology.hl7.org/CodeSystem/utg-concept-properties#v3-internal-id</td><td>code</td><td>The internal identifier for the concept in the HL7 Access database repository.</td></tr><tr><td>Not Selectable</td><td>notSelectable</td><td>http://hl7.org/fhir/concept-properties#notSelectable</td><td>boolean</td><td>Indicates that the code is abstract - only intended to be used as a selector for other concepts</td></tr><tr><td>Status</td><td>status</td><td>http://hl7.org/fhir/concept-properties#status</td><td>code</td><td>Designation of a concept's state. Normally is not populated unless the state is retired.</td></tr></table><p><b>Concepts</b></p><p>This case-sensitive code system <code>http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution</code> defines the following codes in a Is-A hierarchy:</p><table class=\"codes\"><tr><td><b>Lvl</b></td><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td><td><b>internalId</b></td><td><b>Not Selectable</b></td><td><b>Status</b></td></tr><tr><td>1</td><td style=\"white-space:nowrap\">_ActSubstanceAdminSubstitutionCode<a name=\"v3-substanceAdminSubstitution-_ActSubstanceAdminSubstitutionCode\"> </a></td><td>ActSubstanceAdminSubstitutionCode</td><td><div><p>Substitution occurred or is permitted with another product that may potentially have different ingredients, but having the same biological and therapeutic effects.</p>\n</div></td><td>21284</td><td>true</td><td>active</td></tr><tr><td>2</td><td style=\"white-space:nowrap\">\u00a0\u00a0E<a name=\"v3-substanceAdminSubstitution-E\"> </a></td><td>equivalent</td><td><div><p>Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product.</p>\n</div></td><td>23107</td><td/><td>active</td></tr><tr><td>3</td><td style=\"white-space:nowrap\">\u00a0\u00a0\u00a0\u00a0EC<a name=\"v3-substanceAdminSubstitution-EC\"> </a></td><td>equivalent composition</td><td><div><p>Substitution occurred or is permitted with another product that is a:</p>\n<ul>\n<li>pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester</li>\n<li>pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration</li>\n</ul>\n<p><em>Examples:</em></p>\n<ul>\n<li><em>Pharmaceutical alternative:</em> Erythromycin Ethylsuccinate for Erythromycin Stearate</li>\n<li><em>Pharmaceutical equivalent:</em> Lisonpril for Zestril</li>\n</ul>\n</div></td><td>23108</td><td/><td>active</td></tr><tr><td>4</td><td style=\"white-space:nowrap\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0BC<a name=\"v3-substanceAdminSubstitution-BC\"> </a></td><td>brand composition</td><td><div><p>Substitution occurred or is permitted between equivalent Brands but not Generics</p>\n<p><em>Examples:</em></p>\n<ul>\n<li>Zestril for Prinivil</li>\n<li>Coumadin for Jantoven</li>\n</ul>\n</div></td><td>23109</td><td/><td>active</td></tr><tr><td>4</td><td style=\"white-space:nowrap\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0G<a name=\"v3-substanceAdminSubstitution-G\"> </a></td><td>generic composition</td><td><div><p>Substitution occurred or is permitted between equivalent Generics but not Brands</p>\n<p><em>Examples:</em></p>\n<ul>\n<li>Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)</li>\n</ul>\n</div></td><td>16623</td><td/><td>active</td></tr><tr><td>3</td><td style=\"white-space:nowrap\">\u00a0\u00a0\u00a0\u00a0TE<a name=\"v3-substanceAdminSubstitution-TE\"> </a></td><td>therapeutic alternative</td><td><div><p>Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile.</p>\n<p><em>Examples:</em></p>\n<ul>\n<li>ranitidine for Tagamet</li>\n</ul>\n</div></td><td>16624</td><td/><td>active</td></tr><tr><td>4</td><td style=\"white-space:nowrap\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0TB<a name=\"v3-substanceAdminSubstitution-TB\"> </a></td><td>therapeutic brand</td><td><div><p>Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics</p>\n<blockquote>\n</blockquote>\n<p><em>Examples:</em></p>\n<ul>\n<li>Zantac for Tagamet</li>\n</ul>\n</div></td><td>23105</td><td/><td>active</td></tr><tr><td>4</td><td style=\"white-space:nowrap\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0TG<a name=\"v3-substanceAdminSubstitution-TG\"> </a></td><td>therapeutic generic</td><td><div><p>Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands</p>\n<blockquote>\n</blockquote>\n<p><em>Examples:</em></p>\n<ul>\n<li>Ranitidine for cimetidine</li>\n</ul>\n</div></td><td>23106</td><td/><td>active</td></tr><tr><td>2</td><td style=\"white-space:nowrap\">\u00a0\u00a0F<a name=\"v3-substanceAdminSubstitution-F\"> </a></td><td>formulary</td><td><div><p>This substitution was performed or is permitted based on formulary guidelines.</p>\n</div></td><td>16625</td><td/><td>active</td></tr><tr><td>2</td><td style=\"white-space:nowrap\">\u00a0\u00a0N<a name=\"v3-substanceAdminSubstitution-N\"> </a></td><td>none</td><td><div><p>No substitution occurred or is permitted.</p>\n</div></td><td>16622</td><td/><td>active</td></tr></table></div>"
},
"url" : "http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution",
"identifier" : [
{
"system" : "urn:ietf:rfc:3986",
"value" : "urn:oid:2.16.840.1.113883.5.1070"
}
],
"version" : "3.0.0",
"name" : "SubstanceAdminSubstitution",
"title" : "Substance Admin Substitution",
"status" : "active",
"experimental" : false,
"date" : "2019-03-20",
"publisher" : "Health Level Seven International",
"contact" : [
{
"telecom" : [
{
"system" : "url",
"value" : "http://hl7.org"
},
{
"system" : "email",
"value" : "hq@HL7.org"
}
]
}
],
"description" : "Identifies what sort of change is permitted or has occurred between the therapy that was ordered and the therapy that was/will be provided.",
"copyright" : "This material derives from the HL7 Terminology THO. THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license.html",
"caseSensitive" : true,
"hierarchyMeaning" : "is-a",
"content" : "complete",
"property" : [
{
"extension" : [
{
"url" : "http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-symmetry",
"valueCode" : "antisymmetric"
},
{
"url" : "http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-transitivity",
"valueCode" : "transitive"
},
{
"url" : "http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-reflexivity",
"valueCode" : "irreflexive"
},
{
"url" : "http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-isNavigable",
"valueBoolean" : true
},
{
"url" : "http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-relationshipKind",
"valueCode" : "Specializes"
},
{
"url" : "http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-inverseName",
"valueString" : "Generalizes"
}
],
"code" : "Specializes",
"description" : "The child code is a more narrow version of the concept represented by the parent code. I.e. Every child concept is also a valid parent concept. Used to allow determination of subsumption. Must be transitive, irreflexive, antisymmetric.",
"type" : "Coding"
},
{
"extension" : [
{
"url" : "http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-symmetry",
"valueCode" : "antisymmetric"
},
{
"url" : "http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-transitivity",
"valueCode" : "transitive"
},
{
"url" : "http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-reflexivity",
"valueCode" : "irreflexive"
},
{
"url" : "http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-isNavigable",
"valueBoolean" : true
},
{
"url" : "http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-relationshipKind",
"valueCode" : "Generalizes"
},
{
"url" : "http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-inverseName",
"valueString" : "Specializes"
}
],
"code" : "Generalizes",
"description" : "Inverse of Specializes. Only included as a derived relationship.",
"type" : "Coding"
},
{
"code" : "internalId",
"uri" : "http://terminology.hl7.org/CodeSystem/utg-concept-properties#v3-internal-id",
"description" : "The internal identifier for the concept in the HL7 Access database repository.",
"type" : "code"
},
{
"code" : "notSelectable",
"uri" : "http://hl7.org/fhir/concept-properties#notSelectable",
"description" : "Indicates that the code is abstract - only intended to be used as a selector for other concepts",
"type" : "boolean"
},
{
"code" : "status",
"uri" : "http://hl7.org/fhir/concept-properties#status",
"description" : "Designation of a concept's state. Normally is not populated unless the state is retired.",
"type" : "code"
}
],
"concept" : [
{
"code" : "_ActSubstanceAdminSubstitutionCode",
"display" : "ActSubstanceAdminSubstitutionCode",
"definition" : "Substitution occurred or is permitted with another product that may potentially have different ingredients, but having the same biological and therapeutic effects.",
"property" : [
{
"code" : "notSelectable",
"valueBoolean" : true
},
{
"code" : "status",
"valueCode" : "active"
},
{
"code" : "internalId",
"valueCode" : "21284"
}
],
"concept" : [
{
"code" : "E",
"display" : "equivalent",
"definition" : "Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product.",
"property" : [
{
"code" : "status",
"valueCode" : "active"
},
{
"code" : "internalId",
"valueCode" : "23107"
}
],
"concept" : [
{
"code" : "EC",
"display" : "equivalent composition",
"definition" : "Substitution occurred or is permitted with another product that is a:\r\n\r\n * pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester\r\n * pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration\r\n\r\n*Examples:* \r\n\r\n * *Pharmaceutical alternative:* Erythromycin Ethylsuccinate for Erythromycin Stearate\r\n * *Pharmaceutical equivalent:* Lisonpril for Zestril",
"property" : [
{
"code" : "status",
"valueCode" : "active"
},
{
"code" : "internalId",
"valueCode" : "23108"
}
],
"concept" : [
{
"code" : "BC",
"display" : "brand composition",
"definition" : "Substitution occurred or is permitted between equivalent Brands but not Generics\r\n\r\n*Examples:* \r\n\r\n * Zestril for Prinivil\r\n * Coumadin for Jantoven",
"property" : [
{
"code" : "status",
"valueCode" : "active"
},
{
"code" : "internalId",
"valueCode" : "23109"
}
]
},
{
"code" : "G",
"display" : "generic composition",
"definition" : "Substitution occurred or is permitted between equivalent Generics but not Brands\r\n\r\n*Examples:* \r\n\r\n * Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)",
"property" : [
{
"code" : "status",
"valueCode" : "active"
},
{
"code" : "internalId",
"valueCode" : "16623"
}
]
}
]
},
{
"code" : "TE",
"display" : "therapeutic alternative",
"definition" : "Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile.\r\n\r\n*Examples:* \r\n\r\n * ranitidine for Tagamet",
"property" : [
{
"code" : "status",
"valueCode" : "active"
},
{
"code" : "internalId",
"valueCode" : "16624"
}
],
"concept" : [
{
"code" : "TB",
"display" : "therapeutic brand",
"definition" : "Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics\r\n\r\n>\r\n\r\n*Examples:* \r\n\r\n * Zantac for Tagamet",
"property" : [
{
"code" : "status",
"valueCode" : "active"
},
{
"code" : "internalId",
"valueCode" : "23105"
}
]
},
{
"code" : "TG",
"display" : "therapeutic generic",
"definition" : "Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands\r\n\r\n>\r\n\r\n*Examples:* \r\n\r\n * Ranitidine for cimetidine",
"property" : [
{
"code" : "status",
"valueCode" : "active"
},
{
"code" : "internalId",
"valueCode" : "23106"
}
]
}
]
}
]
},
{
"code" : "F",
"display" : "formulary",
"definition" : "This substitution was performed or is permitted based on formulary guidelines.",
"property" : [
{
"code" : "status",
"valueCode" : "active"
},
{
"code" : "internalId",
"valueCode" : "16625"
}
]
},
{
"code" : "N",
"display" : "none",
"definition" : "No substitution occurred or is permitted.",
"property" : [
{
"code" : "status",
"valueCode" : "active"
},
{
"code" : "internalId",
"valueCode" : "16622"
}
]
}
]
}
]
}
IG © 2020+ HL7 International - Vocabulary Work Group. Package hl7.terminology#6.1.0 based on FHIR 5.0.0. Generated 2024-12-21
Links: Table of Contents |
QA Report
| Version History 
|
|
Propose a change